# Body weight and eGFR during dulaglutide treatment in type 2 diabetes and moderate‐to‐severe chronic kidney disease (AWARD‐7)

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/body-weight-and-egfr-during-dulaglutide-treatment-in-type-2-diabetes-and/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Katherine R. Tuttle,Mark Lakshmanan,Brian Rayner,Alan G. Zimmermann,Brad Woodward,Fady T. Botros |
| Citations | 41 |
| DOI | 10.1111/dom.13668 |
| Fields | Biochemistry, Genetics and Molecular Biology,Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W2911578171 |
| PMID | 30762290 |
| Type | article |
| Year | 2019 |

## Paper authors

- [Katherine R. Tuttle](https://scholariq.org/researchers/katherine-r-tuttle/)
- [Brian Rayner](https://scholariq.org/researchers/brian-rayner/)
- [Mark Lakshmanan](https://scholariq.org/researchers/mark-lakshmanan/)
- [Alan G. Zimmermann](https://scholariq.org/researchers/alan-g-zimmermann/)
- [Fady T. Botros](https://scholariq.org/researchers/fady-t-botros/)

## Paper funders

- [Eli Lilly and Company](https://scholariq.org/funders/eli-lilly-and-company/)

## Paper journal

- [Diabetes Obesity and Metabolism](https://scholariq.org/journals/diabetes-obesity-and-metabolism/)

## Paper primary topic

- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)

## Paper topics

- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)
- [Chronic Kidney Disease and Diabetes](https://scholariq.org/topics/chronic-kidney-disease-and-diabetes/)
- [Metabolism, Diabetes, and Cancer](https://scholariq.org/topics/metabolism-diabetes-and-cancer/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.